在MYBPC3变异携带者具有明显或亚临床的多变性心肌病的左下心室喷射时间
Isabell Yan1, Zoe Möhring1, Daniel Reichart2,3
1Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ESC heart failure
|July 4, 2025
概括
患有MYBPC3变异的高性心肌病 (HCM) 患者显示左心室喷射时间指数 (LVETI) 减少,而MYH7变异显示LVETI增加. 在HCM基因型中的这些独特发现可能会为针对sarcomere功能的基因型特异性疗法提供信息.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 生物物理学的生物物理.
背景情况:
- 增高性心肌病 (HCM) 是一种遗传性疾病,通常是由MYBPC3和MYH7.7突变引起的.
- 这些突变可以导致心脏收缩率增加,但对心缩功能的具体影响,例如左心室喷射时间 (LVET),尚未完全理解.
- 之前在小鼠身上进行的研究表明,Mybpc3 缺乏和心功能改变之间存在联系.
研究的目的:
- 调查左心室喷射时间指数 (LVETI) 是否在患有MYBPC3和MYH7.7病原变异的患者中特别发生变化.
- 分析基因型定义的HCM队列的回声心脏学数据,以确定LVETI的不同模式.
- 探索HCM中潜在的基因型特异生物物理后果.
主要方法:
- 对166名患有MYBPC3或MYH7变异的HCM患者和44名健康对照者的回顾性心声分析.
- 测量和调整左心室喷射时间 (LVET) 的心率,以获得LVET指数 (LVETI).
- 变异载体的分层分为 (LVH+) 和 (LVH-) 没有左心室缩的变异载体,使用MANOVA进行统计分析,并对潜在的混因素进行调整.
主要成果:
- 与健康对照人群相比,MYBPC3变异携带者中的LVETI显著较低,MYH7变异携带者中的LVETI较高,在LVH+和LVH-组中观察到.
- MYBPC3变种主要是截断 (87%),而MYH7变种是错误的.
- 这些独特的LVETI模式在发现,验证和聚合队伍中一致.
结论:
- MYBPC3和MYH7中的致病变体导致左心室喷射时间指数 (LVETI) 的明显变化,可通过心声学检测.
- 在HCM患者中,这些基因型特异的生物物理差异可能对开发有针对性的治疗策略产生影响.
- 测量LVETI可能有助于了解疾病机制,并指导HCM个性化治疗方法.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
61
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
61
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy V: Interprofessional Care
38
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
38
Mitral Stenosis II: Clinical features and Diagnostic Tests
39
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Cardiomyopathy I: Introduction and Classification
71
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
71
Mitral Regurgitation I: Introduction
61
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
61


